SCHEMBL17599529

SCHEMBL17599529

CCCCCC(Oc1cc(NS(=O)(=O)c2c(C)c(C)cc(C)c2C)c2ccccc2c1)C(=O)OCC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.41
▸ KMT2A Q03164 3/20 0.41
▸ ALDH1A1 P00352 3/20 0.41
▸ HPGD P15428 3/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ HSD17B10 Q99714 2/20 0.41
▸ CRHBP P24387 1/20 0.41
▸ CRHR2 Q13324 1/20 0.41
▸ CDC25B P30305 2/20 0.38
▸ ALDH2 P05091 2/20 0.38
▸ MAPT P10636 4/20 0.37
▸ KEAP1 Q14145 3/20 0.37
▸ LMNA P02545 1/20 0.37
▸ NFE2L2 Q16236 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ CDC25A P30304 1/20 0.36
▸ CDC25C P30307 1/20 0.36
▸ PPARG P37231 2/20 0.35
▸ PPARA Q07869 2/20 0.35
▸ TP53 P04637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17599523 0.92 PPARG (0.45) KDM4EKMT2AALDH1A1HPGDMEN1
SCHEMBL17599543 0.77 KDM4E (0.43) KDM4EKMT2AALDH1A1HPGDMEN1
SCHEMBL17599528 0.77 ALDH2 (0.44) KDM4EKMT2AALDH1A1HSD17B10CDC25B
SCHEMBL17599536 0.76 KDM4E (0.47) KDM4EKMT2AALDH1A1HPGDMEN1
SCHEMBL27709801 0.74 PPARG (0.59) ALDH2LMNAPPARGPPARAGAA
SCHEMBL10727383 0.74 PPARG (0.59) ALDH2LMNAPPARGPPARAGAA
SCHEMBL17599537 0.73 L3MBTL1 (0.43) KDM4EKMT2AALDH1A1HPGDCRHBP
SCHEMBL17614126 0.71 KDM4E (0.41) KDM4EKMT2AALDH1A1HPGDMEN1
SCHEMBL17599533 0.71 KDM4E (0.44) KDM4EKMT2AALDH1A1HPGDMEN1
SCHEMBL17599531 0.71 KDM4E (0.44) KDM4EKMT2AALDH1A1HPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2998292-A1 Naphthyl sulfonamide derivatives as KEAP-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders SANOFI (FR) 2016-03-23 — — EP disclosed
EP-2998292-A1 Naphthyl sulfonamide derivatives as KEAP-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders SANOFI (FR) 2016-03-23 — — EP disclosed
Send feedback